Hausmaninger, Hubert <br/><br/>
Gemcitabine combined with epirubicin in the treatment of patients with locally advanced or metastatic breast cancer: a phase II study.  [electronic resource] 

 -  American journal of clinical oncology  Aug 2004 
 - 429-35 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-453X 
<br/><br/><label>Standard No.: </label>10.1097/01.coc.0000128527.95562.ae  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Carcinoma, Ductal, Breast--drug therapy<br/>Carcinoma, Lobular--drug therapy<br/>Deoxycytidine--administration & dosage<br/>Epirubicin--administration & dosage<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Survival Analysis<br/>Gemcitabine